| Literature DB >> 34768562 |
Clifton J Holmes1,2, Mary K Hastings1.
Abstract
Diabetic peripheral neuropathy (DPN) is the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after the exclusion of other causes. It is associated with pain, paresthesia, sensory loss, muscle atrophy with fat infiltration, and muscular dysfunction typically starting distally in the feet and progressing proximally. Muscle deterioration within the leg and foot can lead to muscle dysfunction, reduced mobility, and increases the risk of disability, ulceration, and amputation. Exercise training is an established method for increasing the different components of physical fitness, including enhancing body composition and improving neuromuscular strength. A number of experimental studies have utilized exercise training to treat various impairments associated with DPN, such as nerve conduction velocity, pain tolerance, and balance. However, the broad spectrum of exercise training modalities implemented and differences in target outcome measurements have made it difficult to understand the efficacy of exercise training interventions or provide appropriate exercise prescription recommendations. Therefore, the aims of this review were to (1) briefly describe the pathophysiology of DPN and (2) discuss the effects of exercise training interventions on sensorimotor, metabolic, and physical functions in people with DPN.Entities:
Keywords: diabetes mellitus; hyperglycemia; physical training; sensorimotor; therapy
Year: 2021 PMID: 34768562 PMCID: PMC8584831 DOI: 10.3390/jcm10215042
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Summary of exercise training intervention studies in individuals with diabetic peripheral neuropathy.
| Author (Year) | Participants | Primary Measures | Intervention | Key Results | ||||
|---|---|---|---|---|---|---|---|---|
| Type | Frequency | Time | Intensity | Duration | ||||
| Mueller (2013) [ | Weight-bearing (15); non-weight-bearing (14) | 6-min walk and daily step count | Mobility and functional movement | 3 days/week | 60 min/session | 60–70% MHR | 12 weeks | Weight-bearing group: greater improvements in 6-min walk and daily step count; non-weight-bearing group: greater improvements in HbA1c. |
| El-Refay and Ali (2014) [ | Control (15); experimental (15) | Gait | Mobility and functional movement | 3 days/week | 45–60 min/session | --- | 8 weeks | Increased walking speed, cadence, and ankle ROM; decreased step time |
| Sartor (2014) [ | Control (29); experimental (26) | Gait | Mobility and functional movement | 2 days/week | 40–60 min/session | --- | 12 weeks | No significant change in foot rollover during gait |
| Kanchanasamut and Pensri (2017) [ | Control (10); experimental (11) | Foot mobility, plantar pressure, and foot sensation | Mobility and functional movement | 5 days/week | --- | --- | 8 weeks | Increased ROM and decrease peak plantar pressure |
| Win (2020) [ | Control (53); experimental (51) | Activities of daily living, DPN signs/symptoms, and pain | Mobility and functional movement | 3 sessions/day; 2–3 days/week | 10 min/session | --- | 8 weeks | Improvements in motor scores and activities of daily living |
| Monteiro (2020) [ | Control (15); experimental (15) | Strength, PA, gait speed, ROM, DPN symptoms, and QOL | Mobility and functional movement | 2 days/week | 50 min/session | --- | 12 weeks | Improvements in toe strength, gait, DPM symptoms, and foot contact pressure |
| Dixit (2014) [ | Control (37); experimental (29) | Neuropathy quality of life | Aerobic | 5–6 days/week | 150–360 min/week | 40–60% HRR | 8 weeks | Improved neuropathy quality of life total score |
| Dixit (2014) [ | Control (37); experimental (29) | Nerve conduction studies and MDNS | Aerobic | 3–6 days/week | 150–360 min/week | 40–60% HRR | 8 weeks | MDNS scores decreased and NCV increased |
| Morrison (2014) [ | Non-DPN (21); DPN (16) | Gait, reactions, fall risk, and balance | Aerobic | 3 days/week | 30–45 min/session | 50–75% HRR | 12 weeks | Reaction time decreased, gait velocity and stride/step length increased, balance and postural coordination improved |
| Zhang (2014) [ | Control (30); experimental (30) | Plantar pressure | Aerobic | 3 days/week | 20–40 min/session | 100–120 bpm | 12 weeks | Peak plantar pressure in forefoot decreased while pressure in the medial foot increased |
| Hamed (2014) [ | DPN (40); HIIT group (20); aerobic group (20) | Leeds Assessment of Neuropathic Symptoms/Signs Scale | Aerobic | 3 days/week | Aerobic: 50 min; HIIT: 20 min | Aerobic: 50–60% MHR; HIIT: 85–95% MHR | 15 weeks | HIIT lead to greater reductions in pain outcome compared to moderate aerobic exercise |
| Kluding (2015) [ | Experimental (18) | Adverse events, fatigue, and | Aerobic | 3 days/week | 30–50 min/session | 50–70% | 16 weeks | 57 nonserious adverse events occurred and improvements occurred in general fatigue, physical fatigue, and |
| Yoo (2015) [ | Experimental (14) | Pain intensity and pain interference | Aerobic | 3 days/week | 30–50 min/session | 50–70% | 16 weeks | Pain interference was reduced in walking, normal work, relationship with others, and sleep |
| Dixit (2016) [ | Control (36); experimental (28) | Balance and posture stability | Aerobic | 3–6 days/week | 150–360 min/week | 40–60% HRR | 8 weeks | Moderate improvement on eyes closed sway velocity on foam |
| Billinger (2017) [ | experimental (17) | FMD | Aerobic | 3 days/week | 30–60 min/session | 50–70% | 16 weeks | Improvements in peak diameter and time to peak shear, but not statistically significant |
| Gholami (2018) [ | Control (12); experimental (12) | Nerve conduction studies | Aerobic | 3 days/week | 20–45 min/session | 50–70% HRR | 12 weeks | NCV increased but potential amplitude was not different from control |
| Azizi (2019) [ | Experimental (35) | Nerve conduction studies | Aerobic | 3 days/week | 40–45 min/session | 70–85% MHR | 8 weeks | Improvements in both action potential amplitude and conduction velocity |
| Gholami (2020) [ | Control (15); experimental (16) | FMD, IMT, vessel diameter, and MDNS | Aerobic | 3 days/week | 30–45 min/session | 50–70% HRR | 12 weeks | Significant improvements in FMD and MDNS |
| Handsaker (2016) [ | Control (21); non-DPN (13); DPN (9) | Speed of ankle and knee strength generation | Resistance training | 1 day/week | 60 min/session | 12 RM | 16 weeks | Ankle and knee speed of strength generation were higher in both stair ascent and descent |
| Kluding (2012) [ | Experimental (17) | Pain, MNSI, nerve function, and intraepidermal nerve fiber | Aerobic and resistance training | 3–4 days/week | 30–50 min/session (aerobic) | 50–70% | 10 weeks | Reduction in pain, neuropathic symptoms, and increased intraepidermal nerve fiber branching |
| Taveggia (2014) [ | Control (14); experimental (13) | 6-min walk and 10-m walking test | Aerobic and resistance training | 5 days/week | 60 min/session | --- | 4 weeks | Increased 6-min walk distance |
| Nadi (2017) [ | Control (41); experimental (42) | MNSI | Aerobic and resistance training | 3 days/week | 20–60 min/session | 50–70% MHR; 50% 10RM | 12 weeks | Reduction in numbness, pain, tingling, weakness; increases in sense of touch |
| Stubbs (2019) [ | Control (12); experimental (33) | NCS | Aerobic and resistance training | 3 days/week | >30 min/session | 60–80% | 12 weeks | No alterations in sensory/motor nerve electrodiagnostic |
| Seyedizadeh (2020) [ | Control (10); experimental (12) | Serum kinesin-1 and physical function | Aerobic and resistance training | 3 days/week | ≥60 min | 8–12 RM; 50–65% HRR | 8 weeks | Serum kinesin-1 and aerobic endurance decreased and upper body strength increased (all non-significant) |
| Song (2011) [ | Control (19); experimental (19) | Static/dynamic balance and trunk proprioception | Balance | 2 days/week | 60 min/session | --- | 8 weeks | Postural sway decreased, one-leg stance increased, dynamic balance improved, and trunk repositioning errors decreased |
| LeMaster (2008) [ | Control (38); experimental (41) | Activity level | Balance | 3 days/week | 60 min/session | --- | 12 months | Increase in total daily steps |
| Allet (2010) [ | Control (35); experimental (36) | Gait | Balance | 2 days/week | 60 min/session | --- | 12 weeks | Increased habitual walking speed; improved cadence, gait cycle time, and stance time |
| Kruse (2010) [ | Control (38); experimental (41) | Strength, balance, and falls | Balance | 3 days/week | 60 min/session | --- | 12 months | Small time increase in 1-leg, eyes closed stand |
| Eftekhar-Sadat (2015) [ | Control (17); experimental (17) | TUG, BBS, fall risk, and postural stability | Balance | 3 days/week | --- | --- | 4 weeks | Decrease in TUG, fall risk index, and increase overall stability index |
| Ahmed (2018) [ | Control (15); experimental (45) | Posture stability | Balance | 3 days/week | 60 min/session | --- | 6 weeks | Increased posture stability |
| Boslego (2017) [ | Experimental (15) | BBS, balance confidence, and occupation performance/satisfaction | Yoga | 2 days/week | 60 min/session | --- | 8 weeks | Improvements in BBS, balance confidence, and occupation performance/satisfaction |
| Kanjirathingal (2021) [ | Yoga (11); conventional (10); control (14) | Balance, center of pressure, chair stand, and step-up test | Yoga | 3 days/week | 60 min/session | --- | 12 weeks | Improvements in balance, center of pressure, chair stand, and step-up test |
| Ahn and Song (2012) [ | Control (19); experimental (20) | Glucose control, neuropathy score, balance, and quality of life | Tai-chi | 2 days/week | 60 min/session | --- | 12 weeks | Improved glucose control, balance, neuropathic symptoms, and quality of life |
| Handsaker (2019) [ | Control (7); experimental (24) | Stepping accuracy | Proprioception | 1 day/week | 60 min/session | --- | 16 weeks | Increased stepping accuracy |
| Grewal (2015) [ | Control (16); experimental (18) | Posture stability and daily physical activity | Proprioception | 2 days/week | 45 min/session | --- | 4 weeks | Reduced center of mass, ankle, and hip joint sway |
| Ahmad (2019) [ | Control (17); experimental (20) | Balance and proprioception | Proprioception | 3 days/week | 50–60 min/session | --- | 8 weeks | Increased one-leg stance, decreased TUG, center of pressure sway, and increased proprioception |
| Hung (2019) [ | DPN-group A (12); DPN-group B (12) | MFES, TUG, BBS, and UST | Proprioception | 3 days/week | 30 min/session | --- | 6 weeks | Improvements occurred in BBS, right-leg UST, and TUG test scores |
| Rehab and Saleh (2019) [ | Control (15); experimental (15) | Gait and risk of falling | Proprioception | 3 days/week | 30 min/session | --- | 8 weeks | Increased step length, velocity and cadence; decreased risk of falling |
| Kessler (2013) [ | Experimental (8) | Neuropathic pain scale and visual analog pain scale | Whole body vibration | 3 days/week | 12 min/session | 25 Hz and 5 mm amplitude | 4 weeks | Reductions in both pain scales |
| Lee (2013) [ | WBV/balance (19); balance (18); control (18) | Balance, muscle strength, and HbA1c | Whole body vibration | 2 days/week (balance); 3×3 min/day | 60 min/session | --- | 6 weeks | Combined vibration and balance training improved static balance, muscle strength, and HbA1c |
| Kessler (2020) [ | Control (8); experimental (12) | Visual analog pain scale | Whole body vibration | 3 days/week | 12 min/session | 25 Hz and 0.5–1.0 g | 4 weeks | Significant reductions in pain after 2 and 4 weeks |
BBS = Berg Balance Scale; DPN = diabetic peripheral neuropathy; FMD = flow-mediated dilation; HbA1c = glycated hemoglobin; HIIT = high-intensity interval training; HRR = heart rate recovery; IMT = intima media thickness; MDNS = Michigan Diabetic Neuropathy Screen; MFES = modified falls efficacy scale; MHR = maximum heart rate; MNSI = Michigan Neuropathy Screening Instrument; NCV = nerve conduction velocity; PA = physical activity; QOL = quality of life; ROM = range of motion; RPE = ratings of perceived exertion; TUG = Timed Up And Go; UST = unipedal stance test; 2 = oxygen uptake.